(Q37663771)

21 August 2017

TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine (English)

1 reference

21 August 2017

0 references

12

Bert Vogelstein

0 references

Enrico Munari

Enrico Munari

2

0 references

Luis Alberto Diaz Jr

Luis A Diaz

10

0 references

Kenneth W. Kinzler

11

Kenneth W Kinzler

1 reference

21 August 2017

4

Ralph H Hruban

1 reference

21 August 2017

14

George J Netto

1 reference

21 August 2017

8

Simeon Springer

1 reference

21 August 2017

Nickolas Papadopoulos

13

Nickolas Papadopoulos

1 reference

21 August 2017

1

Isaac Kinde

1 reference

21 August 2017

6

Trinity Bivalacqua

1 reference

21 August 2017

Sheila F Faraj

3

1 reference

21 August 2017

Mark Schoenberg

5

1 reference

21 August 2017

Mohamad Allaf

7

1 reference

21 August 2017

Yuxuan Wang

9

1 reference

21 August 2017

language of work or name

English

0 references

publication date

11 October 2013

1 reference

21 August 2017

1 reference

21 August 2017

73

1 reference

21 August 2017

7162-7167

1 reference

21 August 2017

24

1 reference

Clinical applications of recent molecular advances in urologic malignancies: no longer chasing a "mirage"?

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966102

6 September 2017

Cancer genome landscapes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966102

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966102

Highly recurrent TERT promoter mutations in human melanoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966102

TERT promoter mutations in familial and sporadic melanoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966102

6 September 2017

Cancer statistics, 2013

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966102

Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966102

Detection and quantification of rare mutations with massively parallel sequencing

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966102

Urothelial tumorigenesis: a tale of divergent pathways

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966102

The health economics of bladder cancer: a comprehensive review of the published literature.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966102

Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966102

Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966102

Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966102

Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancer.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966102

High-grade papillary urothelial carcinoma of the urinary tract: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center

1 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24121487

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Management of low grade papillary bladder tumors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24121487

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/0008-5472.CAN-13-2498

1 reference

21 August 2017

1 reference

21 August 2017

1 reference